Multiple roles of phosphoinositide-specific phospholipase C isozymes

Pann‐Ghill Suh(Pohang University of Science and Technology), Jae‐Il Park(Pohang University of Science and Technology), Lucia Manzoli(University of Bologna), Lucio Cocco(University of Bologna), Joanna Peak(Cancer Research UK), Matilda Katan(Cancer Research UK), Kiyoko Fukami(Tokyo University of Pharmacy and Life Sciences), Tohru Kataoka(Kobe University), Sanguk Yun(Pohang University of Science and Technology), Sung Ho Ryu(Pohang University of Science and Technology)
BMB Reports
June 30, 2008
Cited by 502Open Access
Full Text

Abstract

Phosphoinositide-specific phospholipase C is an effector molecule in the signal transduction process. It generates two second messengers, inositol-1,4,5-trisphosphate and diacylglycerol from phosphatidylinositol 4,5-bisphosphate. Currently, thirteen mammal PLC isozymes have been identified, and they are divided into six groups: PLC-beta, -gamma, -delta, -epsilon, -zeta and -eta. Sequence analysis studies demonstrated that each isozyme has more than one alternative splicing variant. PLC isozymes contain the X and Y domains that are responsible for catalytic activity. Several other domains including the PH domain, the C2 domain and EF hand motifs are involved in various biological functions of PLC isozymes as signaling proteins. The distribution of PLC isozymes is tissue and organ specific. Recent studies on isolated cells and knockout mice depleted of PLC isozymes have revealed their distinct phenotypes. Given the specificity in distribution and cellular localization, it is clear that each PLC isozyme bears a unique function in the modulation of physiological responses. In this review, we discuss the structural organization, enzymatic properties and molecular diversity of PLC splicing variants and study functional and physiological roles of each isozyme.


Related Papers

No related papers found

Powered by citation graph analysis